Top Ten Tips Regarding Fiduciary Obligations to Compliance for Life Sciences Boards
Le Meridien – Mercantile Room, Level B – 333 Battery St
San Francisco, CA
Recent case law provides insight into the type of red flags that are sufficient to overcome the high standard established in the Caremark case for a claim of breach of fiduciary obligations. Regulatory and enforcement authorities have through the years articulated expectations regarding regulatory compliance for governing bodies in the health care ecosystem. Recent updates to these guidances offers additional insights.
Please join us for an interactive discussion of the practical considerations for satisfying fiduciary standards relating to compliance oversight.
For more information, please email Savannah Euler.